UK med­ical re­search group re­veals £100M rare dis­eases pro­gram; Al­lar­i­ty an­nounces $11M of­fer­ing

UK non-prof­it and med­ical re­search group LifeArc is look­ing to push fur­ther in­to rare dis­ease re­search, so it has cre­at­ed a “chal­lenge” to try and get things mov­ing — and in­vest £100 mil­lion in­to rare dis­ease work by 2030.

Dubbed the “Rare Dis­ease Trans­la­tion­al Chal­lenge,” the goal is to ac­cel­er­ate ear­ly-stage re­search, whether in di­ag­nos­tics, po­ten­tial treat­ments or re­pur­pos­ing ex­ist­ing drugs. The chal­lenge will al­so ex­am­ine ac­cess to clin­i­cal tri­als and time for rare dis­ease pa­tients to get an ac­cu­rate di­ag­no­sis, LifeArc added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER